Official Journal of the Japan Association of Endocrine Surgeons and the Japanese Society of Thyroid Surgery
Online ISSN : 2758-8777
Print ISSN : 2186-9545
Development of molecular target therapy for medullary thyroid cancer
Shunji Takahashi
Author information
Keywords: medullary thyroid cancer, vandetanib, lenvatinib, sorafenib
JOURNAL FREE ACCESS FULL-TEXT HTML

2016 Volume 33 Issue 3 Pages 145-150

Details
Full-text HTML Download PDF (632K)
Download citation RIS

(compatible with EndNote, Reference Manager, ProCite, RefWorks)

BIB TEX

(compatible with BibDesk, LaTeX)

Text
How to download citation
Contact us
Abstract
[in Japanese]
Content from these authors

この記事はクリエイティブ・コモンズ [表示 - 非営利 4.0 国際]ライセンスの下に提供されています。
https://creativecommons.org/licenses/by-nc/4.0/deed.ja
Previous article Next article
Favorites & Alerts

Recently viewed articles
Successor

Official Journal of the Japan Association of Endocrine Surgery

Share this page
feedback
 Top